Skip to main content
. 2023 Sep 14;14:1230495. doi: 10.3389/fneur.2023.1230495

Table 1.

Comparison of demographic features and vestibular function tests in AUPV (vestibular neuritis, VN) patients (n = 72) and healthy controls (n = 35).

VN (n = 72) R.VN (n = 37) L.VN (n = 35) HC (n = 35) Value of p (VN-HC) Value of p (R.VN-HC) Value of p (L.VN-HC) Value of p (R.VN-L.VN)
Demographics
Sex, male, n (%) 39 (54.17) 20 (54.05) 19 (54.29) 20 (57.1) 0.758 0.777 0.793 0.984
Age, years, median (95% CI) 60.5 (59–63) 62 (58–65) 60 (58–63) 59 (53–65) 0.421 0.252 0.78 0.379
Education, years, median (95% CI) 12 (12–16) 12 (12–16) 12 (12–16) 16 (11–16) 0.474 0.503 0.539 0.9
MMSE (30 points), median (95% CI) 28 (28–29) 28 (28–29) 29 (28–30) 28 (28–30) 0.581 0.417 0.87 0.455
Right handedness, n (%) 72 (100) 37 (100) 35 (100) 35 (100)
D-VAS 39.95 ± 1.75 41.01 ± 1.07 37.24 ± 1.90 - 0.591
Audio-Vestibular function tests
Acute phase (within 2 days of onset)
Spontaneous nystagmus, mean (°/sec) 13.7 ± 14.5 14.2 ± 11.3 12.9 ± 14.1 - - 0.061
vHIT hVOR mean gain
Ipsilesional, median (95% CI) 0.69 (0.61–0.76) 0.64 (0.53–0.83) 0.72 (0.62–0.76) - - 0.968
Contralesional, median (95% CI) 0.96 (0.94–0.99) 0.94 (0.91–0.98) 0.97 (0.96–1.01) - - 0.178
Presence of corrective saccades, n (%) 58 (80.56) 28 (75.68) 30 (85.71) - - 0.285
Caloric paresis, %, median (95% CI) 66.96 (45.7–98) 68.8 (36.4–110) 66.96 (36.4–111) - - 0.782
Caloric paresis ≥35%, n (%) 48 (66.67) 25 (67.57) 23 (65.71) - - 0.933
Cervical and ocular VEMP
cVEMP p13 mean latency
Ipsilateral, ms, median (95% CI) 13.9 (13.6–14.6) 13.9 (13.6–14.4) 14.2 (13.5–15.3) - - 0.515
Contralateral, ms, median (95% CI) 13.9 (13.5–14.2) 13.6 (13.2–14.2) 14.1 (13.2–14.6) - - 0.48
cVEMP amplitude AR, %, median (95% CI) 21 (13–26) 16 (12–25) 25 (15–31) - - 0.28
cVEMP amplitude AR ≥ 40%, n (%) 11 (15.28) 4 (10.81) 7 (20) - - 0.116
oVEMP n10 mean latency
Ipsilateral, ms, median (95% CI) 11 (10.8–11.8) 11 (10.7–11.8) 11.3 (10.8–12.8) - - 0.118
Contralateral, ms, median (95% CI) 10.7 (10.4–10.8) 10.7 (10.3–10.8) 10.55 (10.2–11) - - 0.624
oVEMP amplitude AR, %, median (95% CI) 26 (17–36) 21.5 (14–45) 27 (14–44) - - 0.925
oVEMP amplitude AR ≥ 40%, n (%) 20 (27.78) 11 (29.73) 9 (25.71) - - 0.855
PTA, dB, median (95% CI) 19.5 (15–24) 20.5 (16–24.5) 15.8 (12.5–24.5) - - 0.396
Recovery phase (follow-up 4 weeks after onset)
vHIT hVOR mean gain -
Ipsilesional, median (95% CI) 0.82 (0.57–1.02) 0.85 (0.57–1.03) 0.76 (0.53–1.06) - - 0.48
Contralesional, median (95% CI) 0.97 (0.93–1.03) 0.96 (0.91–1.01) 0.99 (0.91–1.07) - - 0.41
Presence of corrective saccades, n (%) 22 (30.56%) 9 (24.3%) 13 (37.1%) 0.307

Values are presented as median (95% CI). Statistical significance was calculated using the Mann–Whitney U test. D-VAS, the visual analog scale (VAS) for dizziness; vHIT-ipsi, video head impulse test-ipsilesional; UW, unilateral weakness; VEMP, vestibular evoked myogenic potential; AR, asymmetry ratio; MMSE, mini–mental state examination; PTA, pure tone audiometry; dB, decibel; ms, millisecond.